Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Develop Custom SNP BeadChip for Wellcome Trust Sanger Institute

NEW YORK, Sept. 28 (GenomeWeb News) - Illumina will develop a custom SNP-genotyping BeadChip for the Wellcome Trust Sanger Institute and the Wellcome Trust Case-Control Consortium, the company said today.


The custom Sentrix BeadChip will analyze so-called non-synonymous SNPs that cause amino acid changes in proteins. The chip, to be called cSNP-6 BeadChip, will allow researchers to study 15,000 SNPs on six samples simultaneously, using Illumina's Infinium assay. Its content will be derived from the HapMap project, of which Illumina and the WTSI are participants.


Researchers at the WTSI plan to use the chips to genotype more than 5,000 samples by the end of the year to study four common disease phenotypes. Following this project, Illumina intends to commercialize the microarray and will make its content available at that time.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.